世界の前臨床用フルイディクス・ライフサイエンス研究・臨床応用市場2020-2024

◆英語タイトル:Global Fluidics for Preclinical, Life Science Research, and Clinical Applications Market 2020-2024
◆商品コード:IRTNTR44975
◆発行会社(リサーチ会社):Technavio
◆発行日:2020年8月28日
◆ページ数:約120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア、その他の国
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥324,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、前臨床用フルイディクス・ライフサイエンス研究・臨床応用の世界市場を調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、製品別(ソフトウェア、付属品、精密シリンジポンプ)分析、用途別(臨床、調査)分析、顧客状況、地域別状況、企業状況、企業分析などの項目を掲載しています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・前臨床用フルイディクス・ライフサイエンス研究・臨床応用の世界市場規模:製品別(ソフトウェア、付属品、精密シリンジポンプ)
・前臨床用フルイディクス・ライフサイエンス研究・臨床応用の世界市場規模:用途別(臨床、調査)
・顧客状況
・地域別状況
・企業状況
・企業分析
【レポートの概要】

Global Fluidics for Preclinical, Life Science Research, And Clinical Applications Market 2020-2024
Technavio has been monitoring the fluidics for preclinical, life science research, and clinical applications market and it is poised to grow by $ 1.38 bn during 2020-2024 progressing at a CAGR of 7% during the forecast period. Our reports on fluidics for preclinical, life science research, and clinical applications market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rise in prevalence of chronic diseases driving cellular research and diverse applications of fluidics technology. In addition, rise in prevalence of chronic diseases driving cellular research is anticipated to boost the growth of the market as well.

The fluidics for preclinical, life science research, and clinical applications market analysis includes product segment, application segment and geographical landscapes
Technavio’s fluidics for preclinical, life science research, and clinical applications market is segmented as below:

By Product
• Software and accessories
• Precision syringe pumps

By Application
• Clinical
• Research

By Geographical Landscapes
• North America
• Europe
• Asia
• ROW

This study identifies the increasing R&D expenditure as one of the prime reasons driving the fluidics for preclinical, life science research, and clinical applications market growth during the next few years.

“Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our fluidics for preclinical, life science research, and clinical applications market covers the following areas:
• Fluidics for preclinical, life science research, and clinical applications market sizing
• Fluidics for preclinical, life science research, and clinical applications market forecast
• Fluidics for preclinical, life science research, and clinical applications market industry analysis”

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading fluidics for preclinical, life science research, and clinical applications market vendors that include AMETEK Inc., Blacktrace Holdings Ltd., Fluigent SA, Halma Plc, Harvard Bioscience Inc., IDEX Corp., IMI Plc, M Dialysis AB, Takasago International Corp., and Thermo Fisher Scientific Inc.. Also, the fluidics for preclinical, life science research, and clinical applications market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/fluidics-for-preclinical-life-science-research-and-clinical-applications-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Market characteristics
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o Software and accessories – Market size and forecast 2019-2024
o Precision syringe pumps – Market size and forecast 2019-2024
o Market opportunity by Product
• Market Segmentation by Application
o Market segments
o Comparison by Application
o Clinical – Market size and forecast 2019-2024
o Research – Market size and forecast 2019-2024
o Market opportunity by Application
• Customer Landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o Asia – Market size and forecast 2019-2024
o ROW – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Competitive scenario
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o AMETEK Inc.
o Blacktrace Holdings Ltd.
o Fluigent SA
o Halma Plc
o Harvard Bioscience Inc.
o IDEX Corp.
o IMI Plc
o M Dialysis AB
o Takasago International Corp.
o Thermo Fisher Scientific Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Key Finding 9
• 9: Parent market
• 10: Market characteristics
• 11: Offerings of vendors included in the market definition
• 12: Market segments
• 13: Global – Market size and forecast 2019 – 2024 ($ million)
• 14: Global market: Year-over-year growth 2019 – 2024 (%)
• 15: Five forces analysis 2019 & 2024
• 16: Bargaining power of buyers
• 17: Bargaining power of suppliers
• 18: Threat of new entrants
• 19: Threat of substitutes
• 20: Threat of rivalry
• 21: Market condition – Five forces 2019
• 22: Product – Market share 2019-2024 (%)
• 23: Comparison by Product
• 24: Software and accessories – Market size and forecast 2019-2024 ($ million)
• 25: Software and accessories – Year-over-year growth 2019-2024 (%)
• 26: Precision syringe pumps – Market size and forecast 2019-2024 ($ million)
• 27: Precision syringe pumps – Year-over-year growth 2019-2024 (%)
• 28: Market opportunity by Product
• 29: Application – Market share 2019-2024 (%)
• 30: Comparison by Application
• 31: Clinical – Market size and forecast 2019-2024 ($ million)
• 32: Clinical – Year-over-year growth 2019-2024 (%)
• 33: Research – Market size and forecast 2019-2024 ($ million)
• 34: Research – Year-over-year growth 2019-2024 (%)
• 35: Market opportunity by Application
• 36: Customer landscape
• 37: Market share by geography 2019-2024 (%)
• 38: Geographic comparison
• 39: North America – Market size and forecast 2019-2024 ($ million)
• 40: North America – Year-over-year growth 2019-2024 (%)
• 41: Europe – Market size and forecast 2019-2024 ($ million)
• 42: Europe – Year-over-year growth 2019-2024 (%)
• 43: Asia – Market size and forecast 2019-2024 ($ million)
• 44: Asia – Year-over-year growth 2019-2024 (%)
• 45: ROW – Market size and forecast 2019-2024 ($ million)
• 46: ROW – Year-over-year growth 2019-2024 (%)
• 47: Key leading countries
• 48: Market opportunity by geography ($ million)
• 49: Impact of drivers and challenges
• 50: Vendor landscape
• 51: Landscape disruption
• 52: Industry risks
• 53: Vendors covered
• 54: Market positioning of vendors
• 55: AMETEK Inc. – Overview
• 56: AMETEK Inc. – Business segments
• 57: AMETEK Inc. – Key offerings
• 58: AMETEK Inc. – Key customers
• 59: AMETEK Inc. – Segment focus
• 60: Blacktrace Holdings Ltd. – Overview
• 61: Blacktrace Holdings Ltd. – Product and service
• 62: Blacktrace Holdings Ltd. – Key offerings
• 63: Blacktrace Holdings Ltd. – Key customers
• 64: Blacktrace Holdings Ltd. – Segment focus
• 65: Fluigent SA – Overview
• 66: Fluigent SA – Product and service
• 67: Fluigent SA – Key offerings
• 68: Fluigent SA – Key customers
• 69: Fluigent SA – Segment focus
• 70: Halma Plc – Overview
• 71: Halma Plc – Business segments
• 72: Halma Plc – Key offerings
• 73: Halma Plc – Key customers
• 74: Halma Plc – Segment focus
• 75: Harvard Bioscience Inc. – Overview
• 76: Harvard Bioscience Inc. – Business segments
• 77: Harvard Bioscience Inc. – Key offerings
• 78: Harvard Bioscience Inc. – Key customers
• 79: Harvard Bioscience Inc. – Segment focus
• 80: IDEX Corp. – Overview
• 81: IDEX Corp. – Business segments
• 82: IDEX Corp. – Key offerings
• 83: IDEX Corp. – Key customers
• 84: IDEX Corp. – Segment focus
• 85: IMI Plc – Overview
• 86: IMI Plc – Business segments
• 87: IMI Plc – Key offerings
• 88: IMI Plc – Key customers
• 89: IMI Plc – Segment focus
• 90: M Dialysis AB – Overview
• 91: M Dialysis AB – Product and service
• 92: M Dialysis AB – Key offerings
• 93: M Dialysis AB – Key customers
• 94: M Dialysis AB – Segment focus
• 95: Takasago International Corp. – Overview
• 96: Takasago International Corp. – Business segments
• 97: Takasago International Corp. – Key offerings
• 98: Takasago International Corp. – Key customers
• 99: Takasago International Corp. – Segment focus
• 100: Thermo Fisher Scientific Inc. – Overview
• 101: Thermo Fisher Scientific Inc. – Business segments
• 102: Thermo Fisher Scientific Inc. – Key offerings
• 103: Thermo Fisher Scientific Inc. – Key customers
• 104: Thermo Fisher Scientific Inc. – Segment focus
• 105: Currency conversion rates for US$
• 106: Research Methodology
• 107: Validation techniques employed for market sizing
• 108: Information sources
• 109: List of abbreviations



【掲載企業】

AMETEK Inc., Blacktrace Holdings Ltd., Fluigent SA, Halma Plc, Harvard Bioscience Inc., IDEX Corp., IMI Plc, M Dialysis AB, Takasago International Corp., Thermo Fisher Scientific Inc.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の前臨床用フルイディクス・ライフサイエンス研究・臨床応用市場2020-2024]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆